Prosecution Insights
Last updated: November 04, 2026
Application No. 18/732,205

METHOD FOR TREATING OR PREVENTING DRUG-INDUCED LIVER INJURY WITH PEPTIDE COMPOSITION

Non-Final OA
Filed
Jun 03, 2024
Priority
Mar 06, 2024 — TW 113108188
Examiner
COFFA, SERGIO
Art Unit
1658
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Green Abiotechnology Co. Ltd.
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
6m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
463 granted / 757 resolved
+1.2% vs TC avg
Strong +32% interview lift
Without
With
+32.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
58 currently pending
Career history
820
Total Applications
across all art units

Statute-Specific Performance

§101
3.8%
-36.2% vs TC avg
§103
34.5%
-5.5% vs TC avg
§102
16.7%
-23.3% vs TC avg
§112
27.1%
-12.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 757 resolved cases

Prosecution Timeline

Jun 03, 2024
Application Filed
Oct 22, 2026
Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12780871
POLYPEPTIDES RV3 AND RV4 HAVING ANTI-AGING FUNCTION AND APPLICATIONS THEREOF
4y 7m to grant Granted Nov 03, 2026
Patent 12780877
CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS
1y 1m to grant Granted Nov 03, 2026
Patent 12751991
METHODS FOR TREATING PANCREATIC CANCER AND OTHER SOLID TUMORS
3y 11m to grant Granted Oct 06, 2026
Patent 12753206
VIPR2 ANTAGONIST PEPTIDE
4y 0m to grant Granted Oct 06, 2026
Patent 12735464
C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof
6y 10m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
93%
With Interview (+32.2%)
2y 11m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 757 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month